What are Astera Labs, Inc.'s total assets?

Astera Labs, Inc. (ALAB) holds $1.7B in total assets, up 47.9% year over year.

How much debt does Astera Labs, Inc. have?

Astera Labs, Inc. carries $41.9M in total debt against $1.5B of shareholders' equity, a debt-to-equity ratio of 0.03.

How much cash does Astera Labs, Inc. have?

Astera Labs, Inc. holds $148.4M in cash and equivalents.

Can Astera Labs, Inc. cover its short-term obligations?

Its current ratio is 11.30 — current assets exceed current liabilities.

Where does Astera Labs, Inc.'s balance sheet data come from?

Every line is extracted from Astera Labs, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Astera Labs, Inc. ALAB Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Cash and cash equivalents	$148.36M+70.5%	$167.68M+109%	$141.48M+12.2%	$163.4M-61.2%	$86.99M-87.5%
Short-term investments	$1.04B+23.6%	$1.02B+22.3%	$994.02M+30.7%	$902.76M—	$838.3M—
Accounts receivable, net	$285.22M+82.6%	$220.2M+113%	$175.81M+142%	$158.29M+152%	$156.21M+304%
Inventories	$229.4M+55.8%	$220.3M+75.2%	$204.54M+91.8%	$177.29M+114%	$147.26M+175%
Raw materials	$298K+49.7%	$84K-63.3%	$183K-83.1%	$172K—	$199K—
Work in process	$46.57M+65.1%	$35.75M+33.9%	$16.93M+60.1%	$24.1M—	$28.2M—
Finished goods	$13.29M-41.4%	$23.14M+42.1%	$34.55M+171%	$34.33M—	$22.65M—
Prepaid expenses and other current assets	$158.45M+142%	$155.2M+271%	$140.82M+382%	$88.64M+329%	$65.34M+517%
Total current assets	$1.41B+31.3%	$1.36B+34.5%	$1.29B+36.4%	$1.18B—	$1.08B—
Property and equipment, net	$97.17M+146%	$92.04M+158%	$72.48M+106%	$62.08M—	$39.47M—
Accumulated depreciation	$15.43M+122%	$11.72M+101%	$8.88M+82.7%	$7.41M—	$6.96M—
Operating lease right-of-use assets	6.8%—	——	——	——	——
Goodwill	——	——	——	——	——
Other non-current assets	$61.38M+500%	$58.74M+899%	$14.34M+70.6%	$16.04M—	$10.23M—
Total assets	$1.66B+47.9%	$1.53B+45.3%	$1.4B+42.5%	$1.27B—	$1.12B—
Accounts payable	$155.56M+73.7%	$129.26M+80.7%	$113.82M+123%	$106.56M—	$89.58M—
Accrued expenses	$22.76M+63.2%	$46.51M-22.0%	$40.16M+73.9%	$27.27M—	$13.95M—
Operating lease liabilities, current	$5.7M—	——	——	——	——
Total current liabilities	$125.04M+61.8%	$133.04M+53.7%	$100.96M+14.7%	$106.38M—	$77.28M—
Operating lease liabilities, non-current	$36.16M—	——	——	——	——
Operating Lease Liabilities (Total)	$41.85M—	——	——	——	——
Other non-current liabilities	$40.22M+1,310%	$35.15M+1,010%	$28.49M+426%	$29.31M—	$2.85M—
Total liabilities	$165.27M+106%	$168.19M+87.5%	$129.45M+38.5%	$135.69M—	$80.13M—
Common stock	1B0.0%	1B+6,249,900%	1B0.0%	1B—	1B—
Additional paid-in capital	$1.4B+15.4%	$1.35B+15.0%	$1.3B+16.4%	$1.26B—	$1.22B—
Retained earnings	$90.65M+151%	$10.34M+105%	-$34.64M+85.2%	-$125.76M—	-$176.98M—
Accumulated other comprehensive income (loss)	-$780K-138%	$4.31M+912%	$4.1M-7.5%	$2.87M—	$2.03M—
Total stockholders' equity	$1.49B+43.4%	$1.36B+41.3%	$1.27B+43.0%	$1.14B+34.4%	$1.04B+28.8%
Total liabilities and stockholders' equity	$1.66B+47.9%	$1.53B+45.3%	$1.4B+42.5%	$1.27B—	$1.12B—
Cash, Cash Equivalents, and Marketable Securities	$1.04B+15.6%	$1.02B+14.2%	$1.11B+27.9%	$1.03B—	$896.18M—
Available For Sale Securities Debt Securities Current	$1.04B+23.6%	$1.02B+22.3%	$994.02M+30.7%	$902.76M—	$838.3M—
Finished goods	$13.29M-41.4%	$23.14M+42.1%	$34.55M+171%	$34.33M—	$22.65M—
Deferred Tax Assets and Other Non-Current Assets	$61.38M+859%	$58.74M+899%	$38.54M+1,548%	$28.58M—	$6.4M—
Net Investment in Lease	$33.87M—	——	——	——	——
Operating lease right-of-use assets	$33.87M—	——	——	——	——
Other non-current assets	$61.38M+859%	$58.74M+899%	$38.54M+1,548%	$28.58M—	$6.4M—
Property, plant and equipment at cost	$112.6M+143%	$103.76M+150%	$81.36M+103%	$69.48M—	$46.43M—
Operating Lease Right-of-Use Assets in Other Assets	$33.87M—	——	——	——	——
Software and Technology Licenses, Net	$61.38M+859%	$58.74M+899%	$38.54M+1,548%	$28.58M—	$6.4M—
Accrued Contingent Liabilities	$0—	$0—	$0—	$0—	$0—
Accrued Manufacturing Costs	$22.76M+63.2%	$46.51M+57.6%	$40.16M+73.9%	$27.27M—	$13.95M—
Other Commercial Liabilities	$69.23M+44.9%	$90.68M+52.1%	$75.15M+8.1%	$74.81M—	$47.77M—
Accrued Liabilities, Current	$69.23M+44.9%	$90.68M+52.1%	$75.15M+8.1%	$74.81M—	$47.77M—
Compensation and benefits	$22.76M+63.2%	$46.51M+57.6%	$40.16M+73.9%	$27.27M—	$13.95M—
Lease Liability Payments - 2020 (Remaining Three Months)	——	——	——	——	——
Operating Lease Liability Payments - 2024 (Lessee)	——	——	——	——	——
Operating Lease Liability Payments - 2025 (Lessee)	——	——	——	——	——
Lease Liability Payments - Due Year Two	——	——	——	——	——
Lease Liability Payments - Due Year Three	——	——	——	——	——
Lease Liability Payments - Due Year Four	——	——	——	——	——
Lease Liability Payments - Remainder of Fiscal Year	——	——	——	——	——
Operating Lease Liability Payments Due	——	——	——	——	——
Operating Lease Liability - Undiscounted Excess Amount	——	——	——	——	——
Operating Lease Liability Payments - 2026 (Lessee)	——	——	——	——	——
Operating Lease Liability Payments - 2027 (Lessee)	——	——	——	——	——
Operating Lease Liability Payments - 2028 (Lessee)	——	——	——	——	——
Common Stock Par Value Per Share	$0.000.0%	$0.000.0%	$0.000.0%	$0.00—	$0.00—
Common Stock Shares Issued	171.3M+3.9%	170.2M+5.0%	168.9M+6.5%	166.2M—	164.9M—
Common Stock Shares Outstanding	$285.22M+5.1%	$450.34M-35.3%	$553.75M+34.7%	$383.81M—	$271.42M—
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$17K+6.3%	$17K+6.3%	$17K+6.3%	$17K—	$16K—
Number of Exercisable Options	——	——	——	——	——
Number of Vested and Expected to Vest Options	——	——	——	——	——
Share-Based Payment Award Options Outstanding - Number	2.6M-43.1%	2.7M-48.5%	2.8M-64.4%	4.3M—	4.6M—
Weighted Average Exercise Price of Outstanding Options	$0.86+3.6%	$0.86+3.6%	$0.86-1.1%	$0.79—	$0.83—
Weighted Average Exercise Price of Vested and Expected to Vest Options	——	——	——	——	——
Cumulative Cost Basis	$112.6M-87.4%	$103.76M-88.4%	$1.1B+28.1%	$1.02B—	$894.16M—
Accrued production equipment	$412K—	——	——	——	——
Accrued software license costs	$8.79M+2.4%	$7.63M+40.9%	$7.14M+12.3%	$8M—	$8.59M—
Available for sale investments	$1.04B+15.6%	$1.02B+14.2%	$1.11B+27.9%	$1.03B—	$896.18M—
Holdback indemnities	——	——	——	——	——
Warrant eligible for vesting (in shares)	——	——	——	——	——
Warrant exercises (in shares)	——	——	——	——	——
Warrants issuable (in shares)	——	——	——	——	——
Common stock, par value (in dollars per share)	$00.0%	$00.0%	$00.0%	$0—	$0—
Common stock, shares authorized (in shares)	$1B0.0%	$1B0.0%	$1B0.0%	$1B—	$1B—
Common stock, shares issued (in shares)	$171.28M+3.9%	$170.19M+5.0%	$168.9M+6.5%	$166.21M—	$164.91M—
Common Stock, Shares, Outstanding	$171.28M+3.9%	$170.19M+5.0%	$168.9M+6.5%	$166.21M—	$164.91M—
Holdback in connection with acquisitions	——	——	——	——	——
Lessee Operating Lease Liability Payments Due	——	——	——	——	——
Thereafter	——	——	——	——	——
Lessee Operating Lease Liability Undiscounted Excess Amount	——	——	——	——	——
Loss Contingency Estimate Of Possible Loss	$0—	$0—	$0—	$0—	$0—
Operating Lease Weighted Average Discount Rate Percent	$0.07—	——	——	——	——
Other accrued liabilities	——	——	——	——	——
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price	——	——	——	——	——
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number	——	——	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number	$2.62M-43.1%	$2.72M-48.5%	$2.84M-64.4%	$4.28M—	$4.61M—
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number	——	——	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$0.86+3.6%	$0.86+3.6%	$0.86-1.1%	$0.79—	$0.83—
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value	——	——	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value	$285.22M+5.1%	$450.34M-35.3%	$553.75M+34.7%	$383.81M—	$271.42M—
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price	——	——	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value	——	——	——	——	——
Unrecorded Unconditional Purchase Obligation	——	——	——	——	——
Remainder of Fiscal Year 2024	——	——	——	——	——
Unrecorded Unconditional Purchase Obligation	——	——	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Astera Labs, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Astera Labs, Inc.'s total assets?: Astera Labs, Inc. (ALAB) holds $1.7B in total assets, up 47.9% year over year.
How much debt does Astera Labs, Inc. have?: Astera Labs, Inc. carries $41.9M in total debt against $1.5B of shareholders' equity, a debt-to-equity ratio of 0.03.
How much cash does Astera Labs, Inc. have?: Astera Labs, Inc. holds $148.4M in cash and equivalents.
Can Astera Labs, Inc. cover its short-term obligations?: Its current ratio is 11.30 — current assets exceed current liabilities.
Where does Astera Labs, Inc.'s balance sheet data come from?: Every line is extracted from Astera Labs, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.